INDP Indaptus Corp: Uzoq muddatli qarzning kapitalga koeffitsiyenti
Indaptus Therapeutics (INDP) kompaniyasining bozor narxi grafigi immun stimulyatsiyasi orqali qattiq o'smalarga qarshi kurashish usullarini ishlab chiqayotgan kompaniyaning natijalarini aks ettiradi va ko'rsatkich 0.00 darajasida turibdi. Biznes saraton terapiyasi uchun faolsizlashtirilgan bakteriyalardan jasorat bilan foydalanishga tayanadi; biroq, loyihaning barqarorligi mablag'lar yetishmasligi va klinik sinovlarning ilk bosqichlaridagi dori toksikligi xavflari bilan cheklangan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_INDP_-_Indaptus-Therapeutics_-_Long-Term-Debt-to-Capital "INDP: Indaptus Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Indaptus Therapeutics (INDP) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Indaptus Therapeutics|INDP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati indaptusrx.com|INDP - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Indaptus Therapeutics, Inc.|INDP - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Indaptus Therapeutics
Kompaniyaning dastlabki tahlili:INDP, Indaptus Therapeutics Inc
Xavfsiz aktivlar minimal qarz yuklamasi mezoniga asoslanib tanlanadi. Indaptus Therapeutics ushbu yondashuvga amal qilgan holda, qattiq o'smalarni davolash uchun bakterial dori vositalarini ishlab chiqishga investitsiya kiritmoqda. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni umumiy kapital bilan solishtiradi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor moliyaviy leveraj darajasini baholaydi. Ushbu nisbatning kamayishi innovatsion moliyalashtirish tuzilmasining barqarorligini tasdiqlaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Vera Therapeutics Inc (VERA)|Uzoq muddatli qarzning kapitalga nisbati DNTH|Pharvaris Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN (Precigen) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|NKTR (Nektar) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati UPB|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc ZBIO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com (IMNM)|GOSS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati KalVista Pharma KALV|Uzoq muddatli qarzning kapitalga nisbati SEPN (Septerna Corp)|PVLA: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Savara Inc.|rigel.com (RIGL) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AnaptysBio (ANAB)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Astria Therapeutics Inc|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzning kapitalga nisbati RAPT (rapt.com)|Aerovate Therapeutics (JBIO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACRS - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Kyverna Therapeutics, Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Uzoq muddatli kreditlarning kapitalga nisbati|CABA: Uzoq muddatli qarzning o'z kapitaliga nisbati|VTYX (Ventyx Biosciences, Inc) - Uzoq muddatli qarzning kapitalga nisbati|THTX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. (ELDN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Agenus, Inc. AGEN|Uzoq muddatli qarzning o'z kapitaliga nisbati Climb Bio, Inc. (CLYM)|Uzoq muddatli kreditlarning kapitalga nisbati zurabio.com ZURA|Uzoq muddatli qarzning kapitalga nisbati aTyr Pharma, Inc. (ATYR)|ADAG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IMA|STTK (Shattuck Labs) - Uzoq muddatli majburiyatlarning kapitalga nisbati|EQ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Connect Pharma|Uzoq muddatli qarzning kapitalga nisbati IMUX|Uzoq muddatli qarzning kapitalga nisbati ATRA (atarabio.com)|InflaRx (IFRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati X4 Pharmaceuticals Inc. XFOR|ACET (Adicet) - Uzoq muddatli qarzning kapitalga nisbati|Celularity Inc. (CELU) - Uzoq muddatli majburiyatlarning kapitalga nisbati|INMB: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati barinthusbio.com|Kezar Life Sciences, Inc. (KZR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati SAB Biotherapeutics Inc.|AKTX (Akari Therapeutics plc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati enlivex.com (ENLV)|Q32 Bio - Uzoq muddatli qarzning kapitalga nisbati|geovax.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati EDSA (Edesa Biotech)|IBIO - Uzoq muddatli qarzdorlikning kapitalga nisbati|carismatx.com - Uzoq muddatli qarzning kapitalga nisbati|XTLB (XTL Bio) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics Inc. (BOLT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HCW Biologics Inc|Uzoq muddatli qarzning kapitalga nisbati Aptevo Therapeutics APVO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AIM (aimimmuno.com)|Aditxt, Inc. (ADTX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|GRI Bio Corporation - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati XORTX Therapeutics Inc.|HIND - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Revelation Biosciences, Inc. REVB|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AFMD|Allakos Inc. (ALLK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti HOOK (hookipapharma.com)|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Third Harmonic Bio THRD